Home/Filings/4/0000899243-18-018727

4//SEC Filing

Invus Public Equities, L.P. 4

Accession 0000899243-18-018727

CIK 0001062822other

View on SEC.gov Company Profile

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 4:23 PM ET

Size

26.9 KB

Accession

0000899243-18-018727

Insider Transaction Report

Form 4

Period: 2018-06-27

LEXICON PHARMACEUTICALS, INC.LXRX

ARTAL GROUP S A

Director10% Owner

Transactions

Purchase
Common Stock
2018-06-28$12.45/sh+57,724$718,935→ 3,516,214 total(indirect: See Footnotes)
Purchase
Common Stock
2018-06-27$12.54/sh+125,114$1,568,442→ 3,458,490 total(indirect: See Footnotes)

Holdings

Common Stock
(indirect: See Footnotes)
21,321,961
Common Stock
(indirect: See Footnotes)
35,402,689

Minne Pascal

Director10% Owner

Transactions

Purchase
Common Stock
2018-06-28$12.45/sh+57,724$718,935→ 3,516,214 total(indirect: See Footnotes)
Purchase
Common Stock
2018-06-27$12.54/sh+125,114$1,568,442→ 3,458,490 total(indirect: See Footnotes)

Holdings

Common Stock
(indirect: See Footnotes)
35,402,689
Common Stock
(indirect: See Footnotes)
21,321,961

Invus, L.P.

10% Owner

Transactions

Purchase
Common Stock
2018-06-27$12.54/sh+125,114$1,568,442→ 3,458,490 total(indirect: See Footnotes)
Purchase
Common Stock
2018-06-28$12.45/sh+57,724$718,935→ 3,516,214 total(indirect: See Footnotes)

Holdings

Common Stock
(indirect: See Footnotes)
21,321,961
Common Stock
(indirect: See Footnotes)
35,402,689

Invus Public Equities Advisors, LLC

Director10% Owner

Transactions

Purchase
Common Stock
2018-06-28$12.45/sh+57,724$718,935→ 3,516,214 total(indirect: See Footnotes)
Purchase
Common Stock
2018-06-27$12.54/sh+125,114$1,568,442→ 3,458,490 total(indirect: See Footnotes)

Holdings

Common Stock
(indirect: See Footnotes)
35,402,689
Common Stock
(indirect: See Footnotes)
21,321,961

ARTAL INTERNATIONAL SCA

Director10% Owner

Transactions

Purchase
Common Stock
2018-06-28$12.45/sh+57,724$718,935→ 3,516,214 total(indirect: See Footnotes)
Purchase
Common Stock
2018-06-27$12.54/sh+125,114$1,568,442→ 3,458,490 total(indirect: See Footnotes)

Holdings

Common Stock
(indirect: See Footnotes)
35,402,689
Common Stock
(indirect: See Footnotes)
21,321,961

Artal International Management S.A.

Director10% Owner

Transactions

Purchase
Common Stock
2018-06-28$12.45/sh+57,724$718,935→ 3,516,214 total(indirect: See Footnotes)
Purchase
Common Stock
2018-06-27$12.54/sh+125,114$1,568,442→ 3,458,490 total(indirect: See Footnotes)

Holdings

Common Stock
(indirect: See Footnotes)
21,321,961
Common Stock
(indirect: See Footnotes)
35,402,689

Invus Public Equities, LP

Director10% Owner

Transactions

Purchase
Common Stock
2018-06-28$12.45/sh+57,724$718,935→ 3,516,214 total(indirect: See Footnotes)
Purchase
Common Stock
2018-06-27$12.54/sh+125,114$1,568,442→ 3,458,490 total(indirect: See Footnotes)

Holdings

Common Stock
(indirect: See Footnotes)
21,321,961
Common Stock
(indirect: See Footnotes)
35,402,689

Stichting Administratiekantoor Westend

Director10% Owner

Transactions

Purchase
Common Stock
2018-06-28$12.45/sh+57,724$718,935→ 3,516,214 total(indirect: See Footnotes)
Purchase
Common Stock
2018-06-27$12.54/sh+125,114$1,568,442→ 3,458,490 total(indirect: See Footnotes)

Holdings

Common Stock
(indirect: See Footnotes)
21,321,961
Common Stock
(indirect: See Footnotes)
35,402,689

Invus Advisors, L.L.C.

10% Owner

Transactions

Purchase
Common Stock
2018-06-28$12.45/sh+57,724$718,935→ 3,516,214 total(indirect: See Footnotes)
Purchase
Common Stock
2018-06-27$12.54/sh+125,114$1,568,442→ 3,458,490 total(indirect: See Footnotes)

Holdings

Common Stock
(indirect: See Footnotes)
35,402,689
Common Stock
(indirect: See Footnotes)
21,321,961

WESTEND SA

Director10% Owner

Transactions

Purchase
Common Stock
2018-06-28$12.45/sh+57,724$718,935→ 3,516,214 total(indirect: See Footnotes)
Purchase
Common Stock
2018-06-27$12.54/sh+125,114$1,568,442→ 3,458,490 total(indirect: See Footnotes)

Holdings

Common Stock
(indirect: See Footnotes)
21,321,961
Common Stock
(indirect: See Footnotes)
35,402,689

Footnotes (7)

[F1]The purchases were made in accordance with Rule 10b-18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
[F2]The shares reported as purchased on June 27, 2018 were purchased in multiple transactions at actual purchase prices ranging from $12.40 to $12.60 per share and the shares reported as purchased on June 28, 2018 were purchased in multiple transactions at actual purchase prices ranging from $12.22 to $12.76 per share, in each case exclusive of any fees, commissions or other expenses. The price reported reflects the weighted average purchase price for the transactions. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
[F3]These securities are directly held by Invus Public Equities, L.P.
[F4]These securities are directly held by Artal International S.C.A.
[F5]These securities are directly held by Invus, L.P.
[F6]Invus Public Equities Advisors, LLC is the general partner of Invus Public Equities, L.P., and Invus Advisors, L.L.C. is the general partner of Invus, L.P. Artal International S.C.A. is the managing member of each of Invus Public Equities Advisors, LLC and Invus Advisors, L.L.C. The managing partner of Artal International S.C.A. is Artal International Management S.A., both of which are wholly owned subsidiaries of Artal Group S.A., which is a wholly owned subsidiary of Westend S.A., which is a wholly owned subsidiary of Stichting Administratiekantoor Westend (the "Stichting"). Mr. Pascal Minne is the sole member of the board of the Stichting.
[F7]Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.

Documents

2 files

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

→

Entity typeother

Related Parties

filerCIK 0001340097

Filing Metadata

Form type: 4
Filed: Jun 28, 8:00 PM ET
Accepted: Jun 29, 4:23 PM ET
Size: 26.9 KB

View on SEC.gov